Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative response.

MLA

Ratto-Kim, S., et al. “Repeated Immunization with Recombinant Gp160 Human Immunodeficiency Virus (HIV) Envelope Protein in Early HIV-1 Infection: Evaluation of the T Cell Proliferative Response.” The Journal of Infectious Diseases, vol. 179, no. 2, Feb. 1999, pp. 337–44. EBSCOhost, https://doi.org/10.1086/314587.

APA

Ratto-Kim, S., Sitz, K. V., Garner, R. P., Kim, J. H., Davis, C., Aronson, N., Ruiz, N., Tencer, K., Redfield, R. R., & Birx, D. L. (1999). Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative response. The Journal of Infectious Diseases, 179(2), 337–344. https://doi.org/10.1086/314587

Chicago

Ratto-Kim, S, K V Sitz, R P Garner, J H Kim, C Davis, N Aronson, N Ruiz, K Tencer, R R Redfield, and D L Birx. 1999. “Repeated Immunization with Recombinant Gp160 Human Immunodeficiency Virus (HIV) Envelope Protein in Early HIV-1 Infection: Evaluation of the T Cell Proliferative Response.” The Journal of Infectious Diseases 179 (2): 337–44. doi:10.1086/314587.